First Vaccine For Dementia To Be Tested On Humans In Three Years

More than 7 million people in America alone suffer from Alzheimer's disease which is a mental disorder which is caused by dementia. A medical breakthrough paved way for its sure as scientists reveal that they have formulated a vaccine that can possibly protect the individual from developing dementia which can lead to Alzheimer's disease.

A group of medical practitioners from the United States and Australia worked together to come up with a vaccine that could combat the development of dementia that eventually evolves to Alzheimer's disease. ABC reports that the said vaccine could potentially reverse and prevent dementia to avoid the dreaded Alzheimer's disease.

Nikolai Petrovsky, one of the researchers mentioned that the vaccine will be tested on humans in the future. It was then mentioned it will take three to five years for the vaccine to be tested on humans.

"If we are successful in preclinical trials, in three to five years we could be well on the way to one of the most important developments in recent medical history," Pertovsky explained. "It could be used both to give people at a particular age, say 50 years of age when they are perfectly fine, to stop them developing dementia, but potentially also could be given to people at least in the early stages of dementia to actually try and reverse the process."

Petrovsky highlighted that the vaccine's antibodies will slowly remove the proteins from the brain which was planted by the disease. It was added that the researchers will come up with two vaccines. One is intended for tau vaccines, while the other is formulated to focus on the treatment.

It is a known fact that patients suffering from dementia are in line to develop Alzheimer's, thus health care practitioners are focused on looking for the cure. Parent Herald then cited that, scientist are already on their way in easing and slowing down the effects of dementia.

© 2024 ParentHerald.com All rights reserved. Do not reproduce without permission.

Join the Discussion
Real Time Analytics